C E Pfeifle
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation
Papers in
- Co-authors
- Stephen B. Howell (19 shared papers)Maurie Markman (6 shared papers)Richard A. Olshen (1 shared paper)Maurie Markman (4 shared papers)William E. Lucas (4 shared papers)Stephen Cleary (2 shared papers)Paul A. Andrews (2 shared papers)Michael P. Murphy (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer (3 papers)American Journal of Health-System Pharmacy (2 papers)The American Journal of Medicine (1 paper)Medical and Pediatric Oncology (2 papers)
- Partner nations
- United States
In The Last Decade
C E Pfeifle
22 papers receiving 706 citations
Peers
Comparison fields: 5 of 74
- Reproductive Medicine 169
- Pathology and Forensic Medicine 189
- Oncology 259
- Surgery 306
- Hepatology 49
Countries citing papers authored by C E Pfeifle
This map shows the geographic impact of C E Pfeifle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C E Pfeifle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C E Pfeifle more than expected).
Fields of papers citing papers by C E Pfeifle
This network shows the impact of papers produced by C E Pfeifle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C E Pfeifle. The network helps show where C E Pfeifle may publish in the future.
Co-authors
The 22 scholars most cited alongside C E Pfeifle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. | 1983 | 154 |
| 2 | 1985 | 126 | |
| 3 | 1984 | 76 | |
| 4 | 1986 | 73 | |
| 5 | 1984 | 57 | |
| 6 | 1984 | 56 | |
| 7 | 1983 | 41 | |
| 8 | 1985 | 34 | |
| 9 | Intracavitary cisplatin chemotherapy for mesothelioma. | 1985 | 32 |
| 10 | 1985 | 30 | |
| 11 | 1990 | 22 | |
| 12 | 1983 | 16 | |
| 13 | 1981 | 12 | |
| 14 | 1986 | 10 | |
| 15 | 1982 | 8 | |
| 16 | High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose schedule. | 1982 | 8 |
| 17 | 1985 | 5 | |
| 18 | Phase I trial of cytarabine and hydroxyurea. | 1983 | 5 |
| 19 | 1986 | 4 | |
| 20 | 1984 | 4 |
About C E Pfeifle
C E Pfeifle is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Hepatology and Molecular Biology, having authored 23 papers that have together received 776 indexed citations. Recurring topics across this work include Intraperitoneal and Appendiceal Malignancies (6 papers), Chemotherapy-induced organ toxicity mitigation (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Treatment and Pharmacology (3 papers), Dialysis and Renal Disease Management (2 papers), Allergic Rhinitis and Sensitization (2 papers), Cancer therapeutics and mechanisms (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Reproductive Medicine (169 citations), Pathology and Forensic Medicine (189 citations), Oncology (259 citations), Surgery (306 citations) and Hepatology (49 citations). C E Pfeifle has collaborated with scholars based in United States. Frequent co-authors include Stephen B. Howell, Maurie Markman, Richard A. Olshen, Maurie Markman, William E. Lucas, Stephen Cleary, Paul A. Andrews, Michael P. Murphy, Joseph J. Bookstein and Tanya Campbell. Their work appears in journals such as Journal of Clinical Oncology, Cancer, American Journal of Health-System Pharmacy, The American Journal of Medicine and Medical and Pediatric Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.